Asian Spectator

.
Business Advice

.

SINOMED(R) Completes One-Year Follow-Up of the PIONEER-III Eur...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TIANJIN, China, July 13, 2020 /PRNewswire-AsiaNet/-- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Classic Shaker Style Doors for Timeless Elegance

Simple, classic beauty is embodied in Shaker style doorways. These doors have a classic fashion and easy traces, and they originate from the Shaker way of life. They are properly-liked for quite a...

Bak jatuh tertimpa tangga: Krisis iklim mempersulit korban kekerasan berbasis gender mengakses keadilan

Krisis iklim membuat banjir rob tak lagi menjadi kejadian musiman, melainkan bencana sehari-hari (everyday disaster), khususnya bagi penduduk kawasan pantai utara Jawa. Bencana ini berdampak pada berk...

Improving Customer Service in Courier Companies

As courier companies expand, prioritising customer service becomes essential to retain and attract new clients. Enhancing customer service in courier companies like Fast Courier can significantly im...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion